- 87.5k views
Role of Generative AI in Healthcare
Generative AI is revolutionizing healthcare by generating synthetic data that can augment limited datasets, improving the robustness of machine learning models. This technology holds promise in medical imaging by creating high-fidelity synthetic images, aiding in diagnosis and treatment planning. Generative AI enables the simulation of molecular structures, facilitating drug discovery and personalized medicine approaches. In healthcare education, it assists in creating realistic patient simulations for training medical professionals and students. By automating the generation of medical reports and documentation, generative AI streamlines administrative tasks, reducing healthcare providers' workload. Telemedicine benefits from generative AI by enhancing remote diagnosis through the generation of detailed visualizations from patient descriptions. Disease modeling and epidemiological studies leverage generative AI to simulate disease spread and predict outbreak patterns. Ethical considerations surrounding the use of generative AI in healthcare, including patient privacy and bias mitigation, are crucial areas of focus. Continued research and development in generative AI promise further advancements, ultimately improving healthcare delivery and patient outcomes.
About the Speaker
Mr. Tim Morris
Vice President of Commercial International Markets at Elsevier, London, United Kingdom
Mr. Tim Morris is the VP of Commercial International Markets at Elsevier, where he specializes in Clinical Decision Support and Hospital Workflow Solutions on a global scale. With an impressive 35 years of experience in the healthcare sector, Tim earned his BSc in Health Studies from the University of Surrey, United Kingdom. Tim has worked in various capacities, ranging from direct patient care as a nurse in a London A&E department to research, management, and product development roles within the NHS and private health companies. Tim has demonstrated his extensive expertise in decision support and knowledge management systems throughout his tenure at Elsevier, focusing on Clinical Decision Support Solutions. He is currently working on the internationalization of Clinical Key AI, a platform that provides clinicians access to Elsevier’s trusted content delivered through responsible AI.
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Mr. Tim Morris's Talks on Assimilate
- 4th-April-2024, TIME : 12:30PM - 1:30PM
- 0
Generative AI is revolutionizing healthcare by generating synthetic data that can augment limited datasets, improving the robustness of machine learning models. This technology holds promise in medical imaging by creating high-fidelity synthetic images, aiding in diagnosis and treatment planning. Generative AI enables the simulation of molecular structures, facilitating drug discovery and personalized medicine approaches. In healthcare education, it assists in creating realistic patient simulations for training medical professionals and students. By automating the generation of medical reports and documentation, generative AI streamlines administrative tasks, reducing healthcare providers' workload. Telemedicine benefits from generative AI by enhancing remote diagnosis through the generation of detailed visualizations from patient descriptions. Disease modeling and epidemiological studies leverage generative AI to simulate disease spread and predict outbreak patterns. Ethical considerations surrounding the use of generative AI in healthcare, including patient privacy and bias mitigation, are crucial areas of focus. Continued research and development in generative AI promise further advancements, ultimately improving healthcare delivery and patient outcomes.